SEATTLE BIOMEDICAL RESEARCH INSTITUTE: Form 990, tax year 2012

View the entire original 990 at ProPublica ↗

Organization
SEATTLE BIOMEDICAL RESEARCH INSTITUTE (EIN 91-0961784)
Tax period
2012-07-01 to 2013-06-30
Filed
2014-05-12
IRS object ID
201411329349302001
Schema version
2012v2.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2014-05-12T10:53:42-05:00Timestamp
Tax Period End Date2013-06-30TaxPeriodEndDate

Preparer Firm PreparerFirm

FieldValueIRS element (for citing)
EIN911194016EIN

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1CLARK NUBER PSBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line110900 NE 4TH STREET SUITE 1700AddressLine1
CityBELLEVUECity
StateWAState
ZIP Code98004ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2012-07-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN910961784EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1SEATTLE BIOMEDICAL RESEARCH INSTITUTEBusinessNameLine1
FieldValueIRS element (for citing)
Name ControlSEATNameControl
Phone2062567200Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line1307 WESTLAKE AVENUE NORTH NO 500AddressLine1
CitySEATTLECity
StateWAState
ZIP Code981095219ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameLOUIE COFFMANName
TitleSR VP-STRATEGY/BUSINESS DEVTTitle
Phone2062567200Phone
Date Signed2014-05-09DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameJANE M SEARINGName
PTINP00000565PTIN
Phone4254544919Phone
FieldValueIRS element (for citing)
Tax Year2012TaxYear
Build TS2016-02-25 16:41:14ZBuildTS

Form 990 IRS990

Doing Business As DoingBusinessAs

FieldValueIRS element (for citing)
Business Name Line1SEATTLE BIOMEDBusinessNameLine1
FieldValueIRS element (for citing)
Name Of Principal Officer PersonALAN ADEREMNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line1307 WESTLAKE AVENUE NORTH NO 500AddressLine1
CitySEATTLECity
StateWAState
ZIP Code981095219ZIPCode
FieldValueIRS element (for citing)
Gross Receipts36672520GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteWWW.SEATTLEBIOMED.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation1976YearFormation
State Legal DomicileWAStateLegalDomicile
Activity Or Mission DescriptionTO ELIMINATE THE WORLD'S MOST DEVASTATING INFECTIOUS DISEASES.ActivityOrMissionDescription
Nbr Voting Members Governing Body23NbrVotingMembersGoverningBody
Nbr Independent Voting Members22NbrIndependentVotingMembers
Total Nbr Employees360TotalNbrEmployees
Total Nbr Volunteers24TotalNbrVolunteers
Total Gross UBI146807TotalGrossUBI
Net Unrelated Business Txbl Income144107NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year44639249ContributionsGrantsPriorYear
Contributions Grants Current Year33773274ContributionsGrantsCurrentYear
Program Service Revenue Prior Year448862ProgramServiceRevenuePriorYear
Program Service Revenue CY388612ProgramServiceRevenueCY
Investment Income Prior Year133411InvestmentIncomePriorYear
Investment Income Current Year202092InvestmentIncomeCurrentYear
Other Revenue Prior Year2388474OtherRevenuePriorYear
Other Revenue Current Year2043605OtherRevenueCurrentYear
Total Revenue Prior Year47609996TotalRevenuePriorYear
Total Revenue Current Year36407583TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year0GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY0GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year22513121SalariesEtcPriorYear
Salaries Etc Current Year20814023SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year675721TotalFundrsngExpCurrentYear
Other Expense Prior Year27584656OtherExpensePriorYear
Other Expenses Current Year22801068OtherExpensesCurrentYear
Total Expenses Prior Year50097777TotalExpensesPriorYear
Total Expenses Current Year43615091TotalExpensesCurrentYear
Revenues Less Expenses Prior Year-2487781RevenuesLessExpensesPriorYear
Revenues Less Expenses CY-7207508RevenuesLessExpensesCY
Total Assets BOY37339001TotalAssetsBOY
Total Assets EOY26369669TotalAssetsEOY
Total Liabilities BOY16062883TotalLiabilitiesBOY
Total Liabilities EOY12236014TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY21276118NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY14133655NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionSEATTLE BIOMED IS AN INDEPENDENT NON-PROFIT RESEARCH INSTITUTE FOCUSED SOLELY ON THE WORLD'S MOST DEVASTATING INFECTIOUS DISEASES. WE ARE DEDICATED TO REDUCING HUMAN SUFFERING AND SAVING LIVES BY CONVERTING KNOWLEDGE INTO SOLUTIONS. OUR RESEARCH IS THE FOUNDATION FOR NEW VACCINES, DRUGS AND DIAGNOSTICS THAT WILL BENEFIT THOSE WHO NEED IT MOST: THE 14 MILLION WHO WILL OTHERWISE DIE EACH YEAR FROM INFECTIOUS DISEASES. SEATTLE BIOMED IS ONE OF SEVERAL RESEARCH ORGANIZATIONS AROUND THE WORLD THAT ARE PIONEERING THE SYSTEMS BIOLOGY OF INFECTIOUS DISEASE RESEARCH. BECAUSE RESEARCH ON MULTIPLE DISEASES TAKES PLACE ALL UNDER ONE ROOF, SCIENTISTS AT SEATTLE BIOMED HAVE UNIQUE OPPORTUNITIES TO DISCUSS AND COLLABORATE ACROSS RESEARCH AREAS. EVERY DAY, THE SCIENTISTS AT SEATTLE BIOMED STRIVE TO END THE THREAT OF INFECTIOUS DISEASE BY INFLUENCING HOW WE THINK ABOUT THOSE DISEASES, INVENTING NEW SOLUTIONS, AND EDUCATING THE NEXT GENERATION OF SCIENTISTS AND OUR COMMUNITY.MissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
Expense37441213Expense
Revenue286565Revenue
DescriptionAT SEATTLE BIOMED WE SEEK TO CREATE A CLIMATE AND CULTURE THAT ATTRACTS, SUPPORTS AND RETAINS A COMMUNITY OF SCIENTISTS WHO AIM TO INFLUENCE, INVENT AND EDUCATE AT THE HIGHEST LEVEL. SEATTLE BIOMED'S SCIENTISTS SHARE COMMON INTERESTS TO (I) CREATE, USE AND SHARE NEW KNOWLEDGE; (II) APPLY THAT KNOWLEDGE TO DEVELOP NEW TOOLS, MATERIALS AND METHODS USEFUL TO ENABLE AND FACILITATE RESEARCH ON THE CRITICAL PATH, AS WELL AS THE MEANS TO PREVENT, DIAGNOSE AND TREAT DISEASE; AND (III) TRAIN THE NEXT GENERATION OF SCIENTISTS WHO WILL ADD SCIENTIFIC, RESEARCH AND CLINICAL CAPACITY IN THE DEVELOPING WORLD. THE INSTITUTE'S BIOMEDICAL RESEARCH PROGRAM IS FOCUSED ON THE DEVELOPMENT OF VACCINES TO PREVENT, AND DRUGS TO TREAT, VARIOUS INFECTIOUS DISEASES, INCLUDING MALARIA, TUBERCULOSIS, HIV AND OTHER EMERGING NEGLECTED DISEASES SUCH AS AFRICAN SLEEPING SICKNESS. RESEARCH IS FUNDED IN LARGE PART BY VARIOUS INSTITUTES OF THE NATIONAL INSTITUTES OF HEALTH, THE DEPARTMENT OF DEFENSE AND THE BILL AND MELINDA GATES FOUNDATION. MAJOR SCIENTIFIC ADVANCES INCLUDE: THE IDENTIFICATION OF THE INOSITOL PATHWAY AS A DRUG TARGET IN TRYPANOSOMES AND SOLVING THE THREE-DIMENSIONAL STRUCTURES OF OVER 560 PROTEINS FROM MORE THAN 40 BACTERIAL, PROTOZOAN, AND VIRAL STRUCTURES, THEREBY PROVIDING A VALUABLE RESOURCE FOR FUTURE DEVELOPMENT OF DRUGS, VACCINES, AND DIAGNOSTIC TOOLS; IDENTIFYING NEW CANDIDATE MALARIA VACCINES; ELUCIDATING HOW THE MALARIA PARASITE MANIPULATES LIVER CELLS, DISCOVERING HOW PARASITES CAUSE CEREBRAL MALARIA, USING COMPUTATIONAL ANALYSES TO LEARN MORE ABOUT HOW THE IMMUNE SYSTEM RESPONDS TO MALARIA; IDENTIFYING THE ROLE OF SPECIFIC TB PROTEINS IN BACTERIALS PERSISTENCE, DEVELOPING A STREAMLINED APPROACH TO IDENTIFY DRUG TARGETS, ESTABLISHING ASSAYS FOR NEW TB DRUGS, CHARACTERIZING THE HOST RESPONSE TO INFECTION AND VACCINATION, AND DEVELOPING A LOW-COST, POINT-OF-CARE DIAGNOSTIC TEST THAT CAN DETECT ACTIVE TB DISEASE; DISCOVERING WHY PREVIOUSLY TESTED HIV/AIDS VACCINES FAILED TO GENERATE A PROTECTIVE IMMUNE RESPONSE, DESIGNING NEW VACCINE CANDIDATES THAT HAVE BEEN SUCCESSFULLY TESTED IN THE LABORATORY, AND SHEDDING LIGHT ON HOW DIFFERENT VACCINE DESIGNS AFFECT THE CHARACTER OF THE IMMUNE RESPONSE PRODUCED TO A VACCINE.Description

Activity2 Activity2

FieldValueIRS element (for citing)
Expense482068Expense
Revenue102047Revenue
DescriptionBIOQUEST: THE PRIMARY GOAL OF SEATTLE BIOMED'S SCIENCE OUTREACH PROGRAM, BIOQUEST, IS TO PROVIDE A CURRICULUM-RELEVANT, CAREER-INSPIRING, TECHNOLOGY-RICH SCIENCE EDUCATION PROGRAM WITHIN THE CONTEXT OF INFECTIOUS DISEASE RESEARCH TO HIGH SCHOOL STUDENTS, TEACHERS, AND THE GENERAL PUBLIC. WE ARE THE ONLY ORGANIZATION IN THE NATION TO OFFER A 32-PERSON TEACHING LAB, WITHIN THE FOOTPRINT OF AN INFECTIOUS DISEASE RESEARCH INSTITUTE.Description
FieldValueIRS element (for citing)
Total Program Service Expense37923281TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities1LobbyingActivities
Subject To Proxy Tax0SubjectToProxyTax
Donor Advised Funds0DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling0CreditCounseling
Term Or Permanent Endowments0TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities0ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities1ReportOtherLiabilities
Report Fin48 Footnote0ReportFin48Footnote
Independent Audit Financial Stmt1IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt0ConsolidatedAuditFinancialStmt
School0School
Foreign Office0ForeignOffice
Foreign Activities1ForeignActivities
More Than5000 K To Organizations0MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities1FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations0GrantsToOrganizations
Grants To Individuals0GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP1LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity0RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transfers To Exempt Non Chrtbl Org0TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With109672NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Compliance With Backup Witholding1ComplianceWithBackupWitholding
Number Of Employees360NumberOfEmployees
Employment Tax Returns Filed1EmploymentTaxReturnsFiled
Unrelated Business Income1UnrelatedBusinessIncome
Form990-T Filed1Form990-TFiled
Foreign Financial Account0ForeignFinancialAccount
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions1QuidProQuoContributions
Quid Pro Quo Disclosure1QuidProQuoDisclosure
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members23NbrVotingGoverningBodyMembers
Number Independent Voting Members22NumberIndependentVotingMembers
Family Or Business Relationship0FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs0ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders0MembersOrStockholders
Election Of Board Members0ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other1CompensationProcessOther
Investment In Joint Venture1InvestmentInJointVenture
Written Policy Or Procedure1WrittenPolicyOrProcedure
States Where Copy Of Return Is FiledWAStatesWhereCopyOfReturnIsFiled
Own WebsiteXOwnWebsite
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1LOUIE COFFMAN - SR VP-STRATEGYBUSINESS DEV'TBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number2062567200TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line1307 WESTLAKE AVE N 500AddressLine1
CitySEATTLECity
StateWAState
ZIP Code981095219ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (37 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekAverage Hours Per Week RelatedAverageHoursPerWeekRelatedIndividual Trustee Or DirectorIndividualTrusteeOrDirectorReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationOfficerOfficerKey EmployeeKeyEmployeeHighest Compensated EmployeeHighestCompensatedEmployee
KENNETH STUART PHD PRES
EMERITUS (AS OF 1/1/12); TRUSTEE40.000.00X590335031020
TREVOR MOODY
CHAIR AS OF 9/124.000.00X000X
TODD PATRICK
CHAIR THROUGH 9/12; TRUSTEE4.000.00X000X
MARK ASHIDA
VICE CHAIR2.000.00X000X
GREGG BLODGETT
TREASURER3.000.00X000X
DARRYL JOHNSON
SECRETARY3.500.00X000X
ALAN LEVY PHD
TRUSTEE1.000.00X000
ALEXANDRE PORTET
TRUSTEE1.000.00X000
BRYAN WHITE
TRUSTEE1.000.00X000
CHRISTOPHER H PORTER PHD
TRUSTEE2.000.00X000
DAVID R STEWART JD
TRUSTEE1.000.00X000
DEAN ALLEN
TRUSTEE1.000.00X000
JANE A BIDDLE PHD
TRUSTEE2.000.00X000
JANE HEDREEN
TRUSTEE3.000.00X000
KEVIN KELLY JD
TRUSTEE1.000.00X000
KRIS RICHEY CURTIS
TRUSTEE3.000.00X000
MAUD DAUDON
TRUSTEE1.000.00X000
MELISSA YEAGER
TRUSTEE1.000.00X000
MIKE STULL
TRUSTEE THROUGH 9/121.000.00X000
MOYA VAZQUEZ
TRUSTEE4.000.00X000
NEIL MCDONNELL PHARMD
TRUSTEE0.200.00X000
RICHARD BEAR
TRUSTEE0.300.00X000
ROSEMARY BARKER ARAGON
TRUSTEE2.000.00X000
STEVEN CLIFFORD
TRUSTEE1.000.00X000
TERRENCE MEERSMAN
TRUSTEE THROUGH 5/131.000.00X000
ALAN ADEREM
PRESIDENT40.000.00316548037226X
RANDALL HASSLER
COO40.000.00208958033667X
LOUIS COFFMAN
SR VP-STRATEGY/BUSINESS DEV'T40.000.00149925021862X
KAREN BLOCHLINGER
COUNSEL40.000.00150162021448X
DREW HOUSE
SR DIR OF FINANCE THROUGH 10/1340.000.00122746013768X
STEFAN KAPPE
PRINCIPAL INVESTIGATOR40.000.00181434022464X
LEONIDAS STAMATATOS
PRINCIPAL INVESTIGATOR40.000.00177083025038X
PETER MYLER
PRINCIPAL INVESTIGATOR40.000.00158458027879X
JOHN AITCHISON
PRINCIPAL INVESTIGATOR24.000.00143192022494X
THOMAS BLACKWELL
DIRECTOR OF IT40.000.00141939017457X
MALCOLM GARDNER
PRINCIPAL INVESTIGATOR40.000.00141149021099X
RUOBING WANG
PRINCIPAL INVESTIGATOR40.000.00139710020835X
FieldValueIRS element (for citing)
Total Reportable Comp From Org2621639TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs0TotalReportableCompFrmRltdOrgs
Total Other Compensation316257TotalOtherCompensation
Number Individuals GT100 K32NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1CityAddressOfContractor/AddressUS/CityStateAddressOfContractor/AddressUS/StateZIP CodeAddressOfContractor/AddressUS/ZIPCodeDescription Of ServicesDescriptionOfServicesCompensationCompensation
EMERALD BIOSTRUCTURES INC
75 REMITTANCE DRIVE BOX 6529CHICAGOIL60675RESEARCH1579017
UNIVERSITY OF WASHINGTON GRANTS & CONTRA
12455 COLLECTIONS DRIVECHICAGOIL60693RESEARCH1019956
SAGE BIONETWORKS
1100 FAIRVIEW AVE N M1-C108SEATTLEWA98109RESEARCH865606
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVE NSEATTLEWA98109RESEARCH/STATISTICAL SERVICES696710
THE SCRIPPS RESEARCH INSTITUTE
10550 N TORREY PINES ROADLA JOLLACA92037RESEARCH586367
FieldValueIRS element (for citing)
Number Of Contractors GT100 K20NumberOfContractorsGT100K
Fundraising Events318542FundraisingEvents
Government Grants25235664GovernmentGrants
All Other Contributions8219068AllOtherContributions
Noncash Contributions2500NoncashContributions
Total Contributions33773274TotalContributions

Program Service Revenue ProgramServiceRevenue (3 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnRelated Or Exempt Function IncomeRelatedOrExemptFunctionIncome
RESEARCH SUPPORT SRVCS541900279163279163
EDUCATION PROGRAM611600102047102047
PROGRAM SERVICE FEES54190074027402
FieldValueIRS element (for citing)
Total Program Service Revenue388612TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column310079TotalRevenueColumn
Exclusion$310,079ExclusionAmount

Gross Rents GrossRents

FieldValueIRS element (for citing)
Real2141042Real

Less Rental Expenses LessRentalExpenses

FieldValueIRS element (for citing)
Real26402Real

Rental Income Or Loss RentalIncomeOrLoss

FieldValueIRS element (for citing)
Real2114640Real

Net Rental Income Or Loss NetRentalIncomeOrLoss

FieldValueIRS element (for citing)
Total Revenue Column2114640TotalRevenueColumn
Unrelated Business Revenue146807UnrelatedBusinessRevenue
Exclusion$1,967,833ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Other33150Other

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Other141137Other

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Other-107987Other

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column-107987TotalRevenueColumn
Exclusion-$107,987ExclusionAmount
FieldValueIRS element (for citing)
Gross Income Fundraising Events26250GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events318542CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses97398FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

FieldValueIRS element (for citing)
Total Revenue Column-71148TotalRevenueColumn
Exclusion-$71,148ExclusionAmount

Other Revenue Misc OtherRevenueMisc

FieldValueIRS element (for citing)
DescriptionHONORARIUMDescription
Business Code900099BusinessCode
Total Revenue Column100TotalRevenueColumn
Exclusion$100ExclusionAmount

Miscellaneous Revenue MiscellaneousRevenue

FieldValueIRS element (for citing)
Total Revenue Column13TotalRevenueColumn
Exclusion$13ExclusionAmount
FieldValueIRS element (for citing)
Total Other Revenue113TotalOtherRevenue

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column36407583TotalRevenueColumn
Related Or Exempt Function Income388612RelatedOrExemptFunctionIncome
Unrelated Business Revenue146807UnrelatedBusinessRevenue
Exclusion$2,098,890ExclusionAmount

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total2259069Total
Program Services1015127ProgramServices
Management And General1243942ManagementAndGeneral

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total14682290Total
Program Services13925221ProgramServices
Management And General333619ManagementAndGeneral
Fundraising423450Fundraising

Pension Plan Contributions PensionPlanContributions

FieldValueIRS element (for citing)
Total1189301Total
Program Services1050430ProgramServices
Management And General108144ManagementAndGeneral
Fundraising30727Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total1562361Total
Program Services1497739ProgramServices
Management And General16653ManagementAndGeneral
Fundraising47969Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total1121002Total
Program Services990630ProgramServices
Management And General101002ManagementAndGeneral
Fundraising29370Fundraising

Fees For Services Management FeesForServicesManagement

FieldValueIRS element (for citing)
Total351315Total
Program Services220572ProgramServices
Management And General114020ManagementAndGeneral
Fundraising16723Fundraising

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total31962Total
Program Services26832ProgramServices
Management And General4990ManagementAndGeneral
Fundraising140Fundraising

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total79806Total
Program Services68644ProgramServices
Management And General9300ManagementAndGeneral
Fundraising1862Fundraising

Fees For Services Lobbying FeesForServicesLobbying

FieldValueIRS element (for citing)
Total120000Total
Management And General120000ManagementAndGeneral

Fees For Services Other FeesForServicesOther

FieldValueIRS element (for citing)
Total152252Total
Program Services105188ProgramServices
Management And General13410ManagementAndGeneral
Fundraising33654Fundraising

Advertising Advertising

FieldValueIRS element (for citing)
Total2000Total
Management And General2000ManagementAndGeneral

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total267182Total
Program Services232599ProgramServices
Management And General22342ManagementAndGeneral
Fundraising12241Fundraising

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total462701Total
Program Services418815ProgramServices
Management And General31269ManagementAndGeneral
Fundraising12617Fundraising

Occupancy Occupancy

FieldValueIRS element (for citing)
Total5958724Total
Program Services3445806ProgramServices
Management And General2478770ManagementAndGeneral
Fundraising34148Fundraising

Travel Travel

FieldValueIRS element (for citing)
Total272151Total
Program Services249760ProgramServices
Management And General16100ManagementAndGeneral
Fundraising6291Fundraising

Conferences Meetings ConferencesMeetings

FieldValueIRS element (for citing)
Total122206Total
Program Services100591ProgramServices
Management And General21615ManagementAndGeneral

Interest Interest

FieldValueIRS element (for citing)
Total44477Total
Program Services32933ProgramServices
Management And General11238ManagementAndGeneral
Fundraising306Fundraising

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total1715701Total
Program Services1523087ProgramServices
Management And General179914ManagementAndGeneral
Fundraising12700Fundraising

Insurance Insurance

FieldValueIRS element (for citing)
Total235061Total
Program Services213560ProgramServices
Management And General17914ManagementAndGeneral
Fundraising3587Fundraising

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneralFundraisingFundraising
SUBCONTRACTS63841236384123
RESEARCH SUPPLIES4606932459815054093373
LAB/CLINICAL/TECH SVS1101885106563335561691
UBI TAX7757477574

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total815016Total
Program Services757841ProgramServices
Management And General51303ManagementAndGeneral
Fundraising5872Fundraising

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total43615091Total
Program Services37923281ProgramServices
Management And General5016089ManagementAndGeneral
Fundraising675721Fundraising

Cash Non Interest Bearing CashNonInterestBearing

FieldValueIRS element (for citing)
BOY5400BOY
EOY900EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY19862035BOY
EOY9808183EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY6150913BOY
EOY6527765EOY

Accounts Receivable AccountsReceivable

FieldValueIRS element (for citing)
BOY155259BOY
EOY115582EOY

Receivables From Officers Etc ReceivablesFromOfficersEtc

FieldValueIRS element (for citing)
BOY198850BOY
EOY103468EOY

Other Notes Loans Receivable Net OtherNotesLoansReceivableNet

FieldValueIRS element (for citing)
BOY106716BOY
EOY0EOY

Inventories For Sale Or Use InventoriesForSaleOrUse

FieldValueIRS element (for citing)
BOY24758BOY
EOY0EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY569012BOY
EOY348517EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis24328398LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec15203830LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY9488074BOY
EOY9124568EOY

Investments Other Securities InvestmentsOtherSecurities

FieldValueIRS element (for citing)
BOY684672BOY
EOY270702EOY

Other Assets Total OtherAssetsTotal

FieldValueIRS element (for citing)
BOY93312BOY
EOY69984EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY37339001BOY
EOY26369669EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY5932499BOY
EOY5548637EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY6989125BOY
EOY4266831EOY

Mort Notes Pybl Secured Invest Prop MortNotesPyblSecuredInvestProp

FieldValueIRS element (for citing)
BOY2059932BOY
EOY1465000EOY

Other Liabilities OtherLiabilities

FieldValueIRS element (for citing)
BOY1081327BOY
EOY955546EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY16062883BOY
EOY12236014EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY14697212BOY
EOY11276235EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY6578906BOY
EOY2857420EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY21276118BOY
EOY14133655EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY37339001BOY
EOY26369669EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses-7207508ReconcilationRevenueExpenses
Reconcilation Other Changes65045ReconcilationOtherChanges
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited

FS Audited Basis FSAuditedBasis

FieldValueIRS element (for citing)
Financial Statement SeparateXFinancialStatementSeparate
FieldValueIRS element (for citing)
Audit Committee1AuditCommittee
Federal Grant Audit Required1FederalGrantAuditRequired
Federal Grant Audit Performed1FederalGrantAuditPerformed

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research Org170b1 AiiiXMedicalResearchOrg170b1Aiii

Hospital Name And Address HospitalNameAndAddress (4 entries)

CityCityStateState
UNIVERSITY OF WASHINGTON MEDICAL CENTER
SEATTLEWA
WALTER REED ARMY INSTITUTE OF RESEARCH
SILVER SPRINGMD
SEATTLE CHILDREN'S HOSPITAL
SEATTLEWA
BOSTON CHILDREN'S HOSPITAL
BOSTONMA
FieldValueIRS element (for citing)
General ExplanationSCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: THESE HOSPITAL AFFILIATIONS ALLOW SEATTLE BIOMED TO QUALIFY AS A MEDICAL RESEARCH ORGANIZATION.GeneralExplanation

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Volunteers0Volunteers
Paid Staff Or Management0PaidStaffOrManagement
Media Advertisements0MediaAdvertisements
Mailings Members0MailingsMembers
Publications Or Broadcast0PublicationsOrBroadcast
Grants Other Organizations0GrantsOtherOrganizations
Direct Contact Legislators1DirectContactLegislators
Direct Contact Legislators$120,000DirectContactLegislatorsAmount
Rallies Demonstrations0RalliesDemonstrations
Other Activities0OtherActivities
Total Lobbying Expenditures IIB120000TotalLobbyingExpendituresIIB
Not Described In501c30NotDescribedIn501c3

Form990 Schedule C Part IV Form990ScheduleCPartIV

FieldValueIRS element (for citing)
IdentifierEXPLANATION OF LOBBYING ACTIVITIES:Identifier
Return ReferencePART II-B, LINE 1:ReturnReference
ExplanationSEATTLE BIOMED HIRED AN INDEPENDENT LOBBYIST TO LOBBY THE LEGISLATURE ON ISSUES INVOLVING THE ORGANIZATION'S MISSION.Explanation

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovements

FieldValueIRS element (for citing)
Other Cost Or Other Basis11261461OtherCostOrOtherBasis
Depreciation5575759Depreciation
Book Value5685702BookValue

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis12225483OtherCostOrOtherBasis
Depreciation8842724Depreciation
Book Value3382759BookValue

Other Land Buildings OtherLandBuildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis841454OtherCostOrOtherBasis
Depreciation785347Depreciation
Book Value56107BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings9124568TotalOfBookValueLandBuildings
Federal Income Tax Liability84261FederalIncomeTaxLiability

Other Liabilities OtherLiabilities (2 entries)

DescriptionDescriptionAmountAmount
FAIR VALUE OF INTEREST RATE SWAP$8,916
DEFERRED RENT LIABILITY$862,369
FieldValueIRS element (for citing)
Total Of Amounts955546TotalOfAmounts
Tot Revenue Etc Audited Fincl Stmt36477098TotRevenueEtcAuditedFinclStmt
Other Revenues35610OtherRevenues
Revenue Not Rptd F99035610RevenueNotRptdF990
Revenue Subtotal36441488RevenueSubtotal
Other Revenues Not Included-33905OtherRevenuesNotIncluded
Revenue Not Rptd On Fin Stmt-33905RevenueNotRptdOnFinStmt
Total Revenue Per Form99036407583TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt43619561TotExpensesEtcAuditedFinclStmt
Other Expenses Included18669OtherExpensesIncluded
Expenses Not Rptd F99018669ExpensesNotRptdF990
Expenses Subtotal43600892ExpensesSubtotal
Other Expenses Not Included14199OtherExpensesNotIncluded
Expenses Not Rptd On Fin Stmt14199ExpensesNotRptdOnFinStmt
Total Expenses Per Form99043615091TotalExpensesPerForm990

Form990 Schedule D Part XIII Form990ScheduleDPartXIII (4 entries)

IdentifierIdentifierExplanationExplanation
PART XI, LINE 2D - OTHER ADJUSTMENTS:CHANGE IN FAIR MARKET VALUE OF INTEREST RATE SWAP 35,610.
PART XI, LINE 4B - OTHER ADJUSTMENTS:BOOK/TAX DIFFERENCE FROM INVESTMENT IN 307 WESTLAKE, LLC -21,703. RENTAL EXPENSE FROM 307 WESTLAKE, LLC -26,401. INDIRECT SPECIAL EVENT DEDUCTIONS 14,199.
PART XII, LINE 2D - OTHER ADJUSTMENTS:LOSS ON PLEDGES RECEIVABLE 18,669.
PART XII, LINE 4B - OTHER ADJUSTMENTS:INDIRECT SPECIAL EVENT DEDUCTIONS 14,199.

Schedule F IRS990ScheduleF

Accts Actvs Out US Table AcctsActvsOutUSTable (6 entries)

RegionRegionNumber Of OfficesNumberOfOfficesNumber Of EmployeesNumberOfEmployeesType Of Activities ConductedTypeOfActivitiesConductedSpecific Services ProvidedSpecificServicesProvidedTotal ExpendituresTotalExpenditures
EAST ASIA AND THE PACIFIC03PROGRAM SERVICESEMERGING INFECTIONS40681
EUROPE021PROGRAM SERVICESEMERGING INFECTIONS, MALARIA, TB, VIRAL VACCINES55894
SUB-SAHARAN AFRICA04PROGRAM SERVICESMALARIA, VIRAL VACCINES42443
NORTH AMERICA00PROGRAM SERVICESEMERGING INFECTIONS, MALARIA, TB, VIRAL VACCINES27316
MIDDLE EAST AND NORTH AFRICA03PROGRAM SERVICESEMERGING INFECTIONS, VIRAL VACCINES888
NORTH AMERICA011ADMINISTRATIVE SERVICES36358
FieldValueIRS element (for citing)
Subtotal Number Of Offices0SubtotalNumberOfOffices
Subtotal Number Of Employees42SubtotalNumberOfEmployees
Cont Number Of Offices0ContNumberOfOffices
Cont Number Of Employees0ContNumberOfEmployees
Total Number Of Offices0TotalNumberOfOffices
Total Number Of Employees42TotalNumberOfEmployees
Subtotal Amount Spent203580SubtotalAmountSpent
Cont Amount Spent0ContAmountSpent
Total Amount Spent203580TotalAmountSpent
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

FieldValueIRS element (for citing)
IdentifierMETHOD USED TO ACCCOUNT FOR EXPENDITURES:Identifier
ExplanationSCHEDULE F, PART I, LINE 3: SEATTLE BIOMED DOES NOT MAINTAIN ANY FOREIGN OFFICES. SEATTLE BIOMED'S SUB-CONTRACTORS ARE PERFORMING RESEARCH ON BEHALF OF THE ORGANIZATION AROUND THE WORLD. THE ACCRUAL METHOD OF ACCOUNTING IS USED TO ACCOUNT FOR EXPENDITURES.Explanation

Schedule G IRS990ScheduleG

Events Information EventsInformation

FieldValueIRS element (for citing)
Name Of Event1PASSPORT DINNERNameOfEvent1
Gross Receipts Event1333942GrossReceiptsEvent1
Charitable Contributions Event1309717CharitableContributionsEvent1
Gross Revenue Event124225GrossRevenueEvent1
Rent Facility Costs Event16411RentFacilityCostsEvent1
Food And Beverage Event131574FoodAndBeverageEvent1
Entertainment Event120000EntertainmentEvent1
Other Direct Expenses Event135925OtherDirectExpensesEvent1
Name Of Event2HARAMBEE-LUNCHEONNameOfEvent2
Gross Receipts Event210850GrossReceiptsEvent2
Charitable Contributions Event28825CharitableContributionsEvent2
Gross Revenue Event22025GrossRevenueEvent2
Food And Beverage Event23407FoodAndBeverageEvent2
Other Direct Expenses Event281OtherDirectExpensesEvent2
Gross Receipts Total344792GrossReceiptsTotal
Charitable Contributions Total318542CharitableContributionsTotal
Gross Revenue Total Events26250GrossRevenueTotalEvents
Rent Facility Costs Total Events6411RentFacilityCostsTotalEvents
Food And Beverage Total Events34981FoodAndBeverageTotalEvents
Entertainment Total Events20000EntertainmentTotalEvents
Other Direct Expenses Total Events36006OtherDirectExpensesTotalEvents
Direct Expense Summary Events97398DirectExpenseSummaryEvents
Net Income Summary-71148NetIncomeSummary

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Independent ConsultantXIndependentConsultant
Written Employment ContractXWrittenEmploymentContract
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment1SeverancePayment
Supplemental Nonqual Retire Plan0SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments0AnyNonFixedPayments
Initial Contract Exception0InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (12 entries)

TitleTitleBase Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
KENNETH STUART PHD PRES
EMERITUS (AS OF 1/1/12); TRUSTEE294455029588000025000060200621355000
ALAN ADEREM
PRESIDENT31654800000250000122260353774000
RANDALL HASSLER
COO20895800000214410122260242625000
LOUIS COFFMAN
SR VP-STRATEGY/BUSINESS DEV'T1499250000014896069660171787000
KAREN BLOCHLINGER
COUNSEL1501620000015124063240171610000
STEFAN KAPPE
PRINCIPAL INVESTIGATOR1814340000012984094800203898000
LEONIDAS STAMATATOS
PRINCIPAL INVESTIGATOR1770830000017958070800202121000
PETER MYLER
PRINCIPAL INVESTIGATOR15845800000164380114410186337000
JOHN AITCHISON
PRINCIPAL INVESTIGATOR14319200000105000119940165686000
THOMAS BLACKWELL
DIRECTOR OF IT1419390000011334061230159396000
MALCOLM GARDNER
PRINCIPAL INVESTIGATOR1411490000014215068840162248000
RUOBING WANG
PRINCIPAL INVESTIGATOR1397100000013968068670160545000

Form990 Schedule J Part III Form990ScheduleJPartIII

FieldValueIRS element (for citing)
Return ReferencePART I, LINE 4AReturnReference
ExplanationON JANUARY 1, 2012, DR. KEN STUART, FOUNDER AND FORMER PRESIDENT, TRANSITIONED TO THE POSITION OF PRESIDENT EMERITUS. ON THAT DATE, HE WAS PAID A LUMP SUM BONUS OF $295,880 IN LIEU OF DEFERRED COMPENSATION. THIS BONUS WAS INCLUDED AS TAXABLE INCOME IN DR. STUART'S 2012 W-2. DR. STUART ALSO RECEIVED COMPENSATION REPORTED ON HIS W-2 FOR CALENDAR YEAR 2012 FOR HIS SERVICES AND POSITION AS PRINCIPAL INVESTIGATOR.Explanation

Schedule L IRS990ScheduleL

Loan Table LoanTable

FieldValueIRS element (for citing)
Name PersonSTEFAN KAPPENamePerson
Relationship With OrganizationPRINCIPAL INVESTIGATORRelationshipWithOrganization
Purpose Of LoanUNRESTRICTED LOANPurposeOfLoan
Loan From OrganizationXLoanFromOrganization
Original Principal$80,000OriginalPrincipalAmount
Balance Due103468BalanceDue
Default0Default
Approved By Board1ApprovedByBoard
Written Agreement1WrittenAgreement
FieldValueIRS element (for citing)
Total Balance Due103468TotalBalanceDue

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (6 entries)

Return ReferenceReturnReferenceExplanationExplanationIdentifierIdentifier
FORM 990, PART I, LINE 6:VOLUNTEERS INCLUDE UNCOMPENSATED BOARD MEMBERS, WHOSE TIME REPRESENTS 100% OF THE VOLUNTEER HOURS FOR FISCAL YEAR 2013. THE NUMBER OF VOLUNTEERS AND CONTRIBUTED HOURS ARE TRACKED AT EACH MEETING AND EVENT; THE TOTAL HOURS FOR THE CURRENT YEAR WERE 1,846.
FORM 990, PART VI, SECTION B, LINE 11THE RETURN WILL BE REVIEWED IN DETAIL BY THE SENIOR VP OF STRATEGY/BUSINESS DEVELOPMENT. IN ADDITION, THE 990 WILL BE PRESENTED TO THE FINANCE AND AUDIT COMMITTEE. A FINAL DRAFT WILL BE ELECTRONICALLY SENT TO ALL TRUSTEES OF SEATTLE BIOMED. OUR BOARD LIAISON WILL MONITOR THE DISTRIBUTION OF THE RETURN AND WILL COLLECT COMMENTS AND RESPONSES AND REPORT THESE TO THE SENIOR VP OF STRATEGY/BUSINESS DEVELOPMENT PROMPTLY. ANY PERTINENT RESPONSES WILL BE ADDRESSED AND RESOLVED BEFORE THE FINAL TAX RETURN IS FILED.
FORM 990, PART VI, SECTION B, LINE 12CEACH TRUSTEE (AND ALL KEY EMPLOYEES) AND MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS SHALL ANNUALLY SIGN A STATEMENT WHICH AFFIRMS THAT SAID PERSON HAS RECEIVED A COPY OF THE CONFLICT OF INTEREST POLICY, HAS READ AND UNDERSTANDS THE POLICY, AND AGREES TO COMPLY WITH THE POLICY. IF ANY KNOWN CONFLICTS ARISE, THEY ARE SENT TO THE EXECUTIVE COMMITTEE FOR RESOLUTION. A FOLLOWUP WITH THE LEADERSHIP TEAM THEN OCCURS, IF NEEDED. PROCEDURES: 1. DUTY TO DISCLOSE: IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE AND NATURE OF HIS/HER FINANCIAL INTEREST TO THE EXECUTIVE COMMITTEE OF THE BOARD OF TRUSTEES PRIOR TO CONSIDERATION OF THE PROPOSED TRANSACTION OR ARRANGEMENT AND MUST NOT ENTER INTO ANY ARRANGEMENT WHERE THERE IS AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST WITHOUT EXECUTIVE COMMITTEE APPROVAL. 2. DETERMINING WHETHER A CONFLICT OF INTEREST EXISTS: AFTER DISCLOSURE OF THE FINANCIAL INTEREST, THE INTERESTED PERSON SHALL RECUSE HIMSELF/HERSELF WHILE THE FINANCIAL INTEREST IS DISCUSSED AND VOTED UPON. THE EXECUTIVE COMMITTEE SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. 3. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST: A. THE EXECUTIVE COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. B. AFTER EXERCISING DUE DILIGENCE, THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER SEATTLE BIOMED CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. C. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY ATTAINABLE UNDER CIRCUMSTANCES THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST, THE BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED MEMBERS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN SEATTLE BIOMED'S BEST INTEREST AND FOR ITS OWN BENEFIT AND WHETHER THE TRANSACTION IS FAIR AND REASONABLE TO SEATTLE BIOMED AND SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT IN CONFORMITY WITH SUCH DETERMINATION. 4. VIOLATIONS OF THE CONFLICTS OF INTEREST POLICY: A. IF THE BOARD, A COMMITTEE, SEATTLE BIOMED STAFF, OR A TRUSTEE HAS REASONABLE CAUSE TO BELIEVE THAT A TRUSTEE OR A COMMITTEE MEMBER HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL INFORM THE MEMBER OF THE BASIS FOR SUCH BELIEF AND AFFORD THE MEMBER THE OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. B. IF, AFTER HEARING THE RESPONSE FROM THE MEMBER AND MAKING SUCH FURTHER INVESTIGATION AS MAY BE WARRANTED IN THE CIRCUMSTANCES, THE EXECUTIVE BOARD DETERMINES THAT THE MEMBER HAS, IN FACT, FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL TAKE APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION.
FORM 990, PART VI, SECTION B, LINE 15COMPENSATION PLANNING AND REVIEW TAKES PLACE ANNUALLY. HUMAN RESOURCES PROVIDES MARKET DATA FOR EACH POSITION IN THE INSTITUTE. FOR SENIOR LEADERSHIP POSITIONS, SPECIFICALLY KEY EMPLOYEES, AN OUTSIDE COMPENSATION CONSULTANT BENCHMARKS THESE POSITIONS AND PROVIDES DATA AND ANALYSIS, WHICH ALLOWS THE ORGANIZATION'S HUMAN RESOURCES DEPARTMENT TO ESTABLISH A PAY RANGE FOR EACH OF THESE ROLES AT OUR INSTITUTE. THE HUMAN RESOURCES DEPARTMENT ALSO GATHERS INDUSTRY-SPECIFIC INFORMATION FROM OUR PEERS TO VALIDATE THE SURVEY INFORMATION AND TO ENSURE THAT WE REMAIN COMPETITIVE WITH OUR COMPENSATION. THIS INFORMATION IS GATHERED FROM LOCAL PEER ORGANIZATIONS IN OUR INDUSTRY AND/OR FROM PEER ORGANIZATIONS WHO ARE PART OF THE ASSOCIATION OF INDEPENDENT RESEARCH INSTITUTES (AIRI). THE MOST RECENT COMPENSATION REVIEW OF SENIOR POSITIONS (PRIOR TO JUNE 30, 2013) TOOK PLACE IN JANUARY 2012.
FORM 990, PART VI, SECTION C, LINE 19THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST.
FORM 990, PART XI, LINE 9:CHANGE IN FAIR VALUE OF INTEREST RATE SWAP AGREEMENT 35,610. RENTAL EXPENSE FROM 307 WESTLAKE, LLC 26,401. BOOK/TAX DIFFERENCE FROM INVESTMENT IN 307 WESTLAKE, LLC 21,703. LOSS ON PLEDGES RECEIVABLE -18,669.CHANGES IN NET ASSETS OR FUND BALANCES:

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.